<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38240001</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2189-7948</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of general and family medicine</Title><ISOAbbreviation>J Gen Fam Med</ISOAbbreviation></Journal><ArticleTitle>Treatment of long COVID complicated by postural orthostatic tachycardia syndrome-Case series research.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>61</EndPage><MedlinePgn>53-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jgf2.670</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Coronavirus disease 2019 (COVID-19) sequelae, also known as long COVID, can present with various symptoms. Among these symptoms, autonomic dysregulation, particularly postural orthostatic tachycardia syndrome (POTS), should be evaluated. However, previous studies on the treatment of POTS complicated by COVID-19 are lacking. Therefore, this study aimed to investigate the treatment course of long COVID complicated by POTS.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The medical records of patients who complained of fatigue and met the criteria for POTS diagnosis were reviewed. We evaluated the treatment days, methods and changes in fatigue score, changes in heart rate on the Schellong test, and social situation at the first and last visits.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Thirty-two patients with long COVID complicated by POTS were followed up (16 males; median age: 28&#x2009;years). The follow-up period was 159&#x2009;days, and the interval between COVID-19 onset and initial hospital attendance was 97&#x2009;days. Some patients responded to &#x3b2;-blocker therapy. Many patients had psychiatric symptoms that required psychiatric intervention and selective serotonin reuptake inhibitor prescription. Changes in heart rate, performance status, and employment/education status improved from the first to the last visit. These outcomes were believed to be because of the effects of various treatment interventions and spontaneous improvements.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our study suggests that the condition of 94% of patients with POTS complicated by long COVID will improve within 159&#x2009;days. Therefore, POTS evaluation should be considered when patients with long COVID complain of fatigue, and attention should be paid to psychological symptoms and the social context.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Journal of General and Family Medicine published by John Wiley &amp; Sons Australia, Ltd on behalf of Japan Primary Care Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsuchida</LastName><ForeName>Tomoya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8517-3941</Identifier><AffiliationInfo><Affiliation>Department of General Internal Medicine St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishibashi</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Yoko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishizuka</LastName><ForeName>Kosuke</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4313-6592</Identifier><AffiliationInfo><Affiliation>Department of General Internal Medicine St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katayama</LastName><ForeName>Kohta</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8076-7188</Identifier><AffiliationInfo><Affiliation>Department of General Internal Medicine St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirose</LastName><ForeName>Masanori</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakagama</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Virology &amp; Parasitology, Graduate School of Medicine Osaka Metropolitan University Osaka Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Infectious Disease Sciences, Graduate School of Medicine Osaka Metropolitan University Osaka Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kido</LastName><ForeName>Yasutoshi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Virology &amp; Parasitology, Graduate School of Medicine Osaka Metropolitan University Osaka Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Infectious Disease Sciences, Graduate School of Medicine Osaka Metropolitan University Osaka Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akashi</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsubo</LastName><ForeName>Takehito</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological and General Surgery St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuda</LastName><ForeName>Takahide</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohira</LastName><ForeName>Yoshiyuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine St. Marianna University School of Medicine Kawasaki Kanagawa Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Gen Fam Med</MedlineTA><NlmUniqueID>101689875</NlmUniqueID><ISSNLinking>2189-7948</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">postural orthostatic tachycardia syndrome</Keyword><Keyword MajorTopicYN="N">&#x3b2;&#x2010;Blocker</Keyword></KeywordList><CoiStatement>The authors have stated explicitly that there are no conflicts of interest in connection with this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>3</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38240001</ArticleId><ArticleId IdType="pmc">PMC10792321</ArticleId><ArticleId IdType="doi">10.1002/jgf2.670</ArticleId><ArticleId IdType="pii">JGF2670</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization (WHO) coronavirus (COVID&#x2010;19) dashboard. 2022. https://covid19.who.int. Accessed 31 Jul 2023.</Citation></Reference><Reference><Citation>
CDC
. Long COVID or post&#x2010;COVID conditions. 2022. https://www.cdc.gov/coronavirus/2019&#x2010;ncov/long&#x2010;term&#x2010;effects/index.html. Accessed 31 Jul 2023.</Citation></Reference><Reference><Citation>
World Health Organization
. A clinical case definition of post COVID&#x2010;19 condition by a Delphi consensus. 2021. https://www.who.int/publications/i/item/WHO&#x2010;2019&#x2010;nCoV&#x2010;Post_COVID&#x2010;19_condition&#x2010;Clinical_case_definition&#x2010;2021.1. Accessed 31 Jul 2023.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et&#xa0;al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS&#x2010;CoV&#x2010;2. Lancet. 2022;399:2263&#x2013;2264. 10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long&#x2010;term sequelae of COVID&#x2010;19: a systematic review and meta&#x2010;analysis of one&#x2010;year follow&#x2010;up studies on post&#x2010;COVID symptoms. Pathogens. 2022;11:269. 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et&#xa0;al. Symptoms and risk factors for long COVID in non&#x2010;hospitalized adults. Nat Med. 2022;28:1706&#x2013;1714. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et&#xa0;al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11:16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Haloot J, Bhavaraju&#x2010;Sanka R, Pillarisetti J, Verduzco&#x2010;Gutierrez M. Autonomic dysfunction related to oostacute SARS&#x2010;CoV&#x2010;2 syndrome. Phys Med Rehabil Clin N Am. 2023;34:563&#x2013;572. 10.1016/j.pmr.2023.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2023.04.003</ArticleId><ArticleId IdType="pmc">PMC10110930</ArticleId><ArticleId IdType="pubmed">37419532</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Carneiro D, Rocha I, Habek M, Helbok R, Sellner J, Struhal W, et&#xa0;al. Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID&#x2010;19 infection &#x2013; a systematic review. Eur J Neurol. 2023;30:1528&#x2013;1539. 10.1111/ene.15714</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15714</ArticleId><ArticleId IdType="pubmed">36694382</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VM, et&#xa0;al. Long&#x2010;COVID postural tachycardia syndrome: an American autonomic society statement. Clin Auton Res. 2021;31:365&#x2013;368. 10.1007/s10286-021-00798-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et&#xa0;al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting &#x2013; part 1. Auton Neurosci. 2021;235:102828. 10.1016/j.autneu.2021.102828</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102828</ArticleId><ArticleId IdType="pmc">PMC8455420</ArticleId><ArticleId IdType="pubmed">34144933</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et&#xa0;al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69&#x2013;72. 10.1007/s10286-011-0119-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-011-0119-5</ArticleId><ArticleId IdType="pubmed">21431947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadda KR, Blakey EE, Huang CL, Jeevaratnam K. Long COVID&#x2010;19 and postural orthostatic tachycardia syndrome&#x2010; is dysautonomia to be blamed? Front Cardiovasc Med. 2022;9:860198. 10.3389/fcvm.2022.860198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.860198</ArticleId><ArticleId IdType="pmc">PMC8959615</ArticleId><ArticleId IdType="pubmed">35355961</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID&#x2010;19. Clin Auton Res. 2020;30:449&#x2013;451. 10.1007/s10286-020-00727-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00727-9</ArticleId><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi Y, Yoneyama K, Tsuchida T, Akashi YJ. Post&#x2010;COVID&#x2010;19 postural orthostatic tachycardia syndrome. Intern Med. 2021;60:2345. 10.2169/INTERNALMEDICINE.7626-21</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/INTERNALMEDICINE.7626-21</ArticleId><ArticleId IdType="pmc">PMC8355393</ArticleId><ArticleId IdType="pubmed">34053992</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, St&#xe5;hlberg M, Runold M, Nygren&#x2010;Bonnier M, Nilsson J, Olshansky B, et&#xa0;al. Long&#x2010;haul post&#x2013;COVID&#x2010;19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 2021;3:573&#x2013;580. 10.1016/j.jaccas.2021.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2021.01.009</ArticleId><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall NP, James S, Kavi L. Observational case series of postural tachycardia syndrome (PoTS) in post&#x2010;COVID&#x2010;19 patients. Br J Cardiol. 2022;29:3. 10.5837/bjc.2022.003</Citation><ArticleIdList><ArticleId IdType="doi">10.5837/bjc.2022.003</ArticleId><ArticleId IdType="pmc">PMC9196071</ArticleId><ArticleId IdType="pubmed">35747313</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID&#x2010;19 infection: a case series of 20 patients. Immunol Res. 2021;69:205&#x2013;211. 10.1007/s12026-021-09185-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavi L, Nuttall N, Low PA, Opie M, Nicholson L, Caldow E, et&#xa0;al. A profile of patients with postural tachycardia syndrome and their experience of healthcare in the UK. Br J Cardiol. 2016;23:33. 10.5837/bjc.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.5837/bjc.2016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q, Levine BD. Exercise and non&#x2010;pharmacological treatment of POTS. Auton Neurosci. 2018;215:20&#x2013;27. 10.1016/j.autneu.2018.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.07.001</ArticleId><ArticleId IdType="pmc">PMC6289756</ArticleId><ArticleId IdType="pubmed">30001836</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AJ, Raj SR. Pharmacotherapy for postural tachycardia syndrome. Auton Neurosci. 2018;215:28&#x2013;36. 10.1016/j.autneu.2018.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.04.008</ArticleId><ArticleId IdType="pubmed">29753556</ArticleId></ArticleIdList></Reference><Reference><Citation>
[Degree of fatigue and malaise according to PS (performance status) (PS is determined by the physician) In Japanese]. https://www.fuksi&#x2010;kagk&#x2010;u.ac.jp/guide/efforts/research/kuratsune/. Accessed 31 Jul 2023.</Citation></Reference><Reference><Citation>Bhatia R, Kizilbash SJ, Ahrens SP, Killian JM, Kimmes SA, Knoebel EE, et&#xa0;al. Outcomes of adolescent&#x2010;onset postural orthostatic tachycardia syndrome. J Pediatr. 2016;173:149&#x2013;153. 10.1016/j.jpeds.2016.02.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2016.02.035</ArticleId><ArticleId IdType="pubmed">26979650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar PL, Raj V, Black BK, Biaggioni I, Shibao CA, Paranjape SY, et&#xa0;al. Acute hemodynamic effects of a selective serotonin reuptake inhibitor in postural tachycardia syndrome: randomized, crossover trial. J Psychopharmacol. 2014;28:155&#x2013;161. 10.1177/0269881113512911</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881113512911</ArticleId><ArticleId IdType="pmc">PMC3956655</ArticleId><ArticleId IdType="pubmed">24227635</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, et&#xa0;al. Autonomic dysfunction following COVID&#x2010;19 infection: an early experience. Clin Auton Res. 2021;31:385&#x2013;394. 10.1007/s10286-021-00803-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston CK, &#x15a;wi&#x105;tkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID&#x2010;19. Heart Rhythm. 2022;19:1880&#x2013;1889. 10.1016/j.hrthm.2022.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimpinski K, Figueroa JJ, Singer W, Sletten DM, Iodice V, Sandroni P, et&#xa0;al. A prospective, 1&#x2010;year follow&#x2010;up study of postural tachycardia syndrome. Mayo Clin Proc. 2012;87:746&#x2013;752. 10.1016/j.mayocp.2012.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.02.020</ArticleId><ArticleId IdType="pmc">PMC3538485</ArticleId><ArticleId IdType="pubmed">22795533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et&#xa0;al. Diverse functional autoantibodies in patients with COVID&#x2010;19. Nature. 2021;595:283&#x2013;288. 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharraziha I, Axelsson J, Ricci F, Di Martino G, Persson M, Sutton R, et&#xa0;al. Serum activity against G protein&#x2010;coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome. J Am Heart Assoc. 2020;9:e015989. 10.1161/JAHA.120.015989</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.015989</ArticleId><ArticleId IdType="pmc">PMC7792263</ArticleId><ArticleId IdType="pubmed">32750291</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, et&#xa0;al. The face of postural tachycardia syndrome &#x2013; insights from a large cross&#x2010;sectional online community&#x2010;based survey. J Intern Med. 2019;286:438&#x2013;448. 10.1111/joim.12895</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12895</ArticleId><ArticleId IdType="pmc">PMC6790699</ArticleId><ArticleId IdType="pubmed">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai K, Yamano T, Nishi S, Nishi R, Nishi T, Tanaka H, et&#xa0;al. Epipharyngeal abrasive therapy (EAT) has potential as a novel method for long COVID treatment. Viruses. 2022;14:907. 10.3390/v14050907</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14050907</ArticleId><ArticleId IdType="pmc">PMC9147901</ArticleId><ArticleId IdType="pubmed">35632649</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley MC, Gallagher C, Ong E, Langdon A, Chieng J, Bailey D, et&#xa0;al. High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long COVID: implications for management and health care planning. Am J Med. 2023;S0002&#x2010;9343(23)00402&#x2010;3. 10.1016/j.amjmed.2023.06.010 [In press].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.06.010</ArticleId><ArticleId IdType="pmc">PMC10307671</ArticleId><ArticleId IdType="pubmed">37391116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>